Company intelligence / Profile preview

Biomedical Growth Strategies

Carlisle, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Biomedical Growth Strategies is a private strategic advisory firm serving the life sciences and healthcare industries. The company is led by Susan Windham-Bannister, a longtime biopharma strategist and former President and CEO of the Massachusetts Life Sciences Center. Based on publicly available descriptions, the firm focuses on biopharma innovation, market access, market optimization, and advising innovation initiatives in the U.S. and internationally. It does not appear to be a drug developer with a disclosed therapeutic pipeline; instead, it operates as an advisory and strategy business supporting organizations across biotech, pharma, medtech, diagnostics, and healthcare.

Industry: Consulting

Beyond the preview

Go deeper on Biomedical Growth Strategies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomedical Growth Strategies.

Explore the full profile